Qulipta 30 mg/1 (Atogepant TABLET) 30 mg/1

Qulipta 30 mg tablets are a medication used for preventive treatment of migraines. This oral tablet, manufactured by AbbVie Inc., is designed to help reduce the frequency of migraine episodes. Learn more about Qulipta's uses and effects.

Strength

30 mg/1

Pack Size

4 TABLET in 1 BOTTLE (0074-7096-04)

Manufacturer / TM Owner

AbbVie Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Qulipta 30 mg tablets are primarily used for the preventive treatment of migraines. This medication is designed to help reduce the number of migraine days experienced by individuals who suffer from this condition. Qulipta is not intended for the acute treatment of migraines but rather for long-term prevention. People often ask, 'What is Qulipta used for?' and the answer is that it is used to manage and prevent migraines, helping individuals maintain a better quality of life.

Side Effects

Common effects of Qulipta 30 mg tablets may include nausea, constipation, and fatigue. Some individuals might experience upper respiratory tract infection or muscle pain. These effects can vary from person to person, and it's important to consult with a healthcare provider for personalized advice. Always follow the guidance of a medical professional when taking any medication.

Precautions & Warnings

When handling Qulipta 30 mg tablets, it's important to store them as directed and follow the prescribed dosage. This medication should be kept out of reach of children and pets. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions. Proper storage and handling are crucial for maintaining the effectiveness of Qulipta.

Avoid Interactions

Qulipta 30 mg tablets may interact with certain medications, including strong CYP3A4 inhibitors and inducers. It's important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and other substances may also affect the way Qulipta works, so it's best to consult with a medical professional for personalized advice.

Frequently Asked Questions

Qulipta is used for the preventive treatment of migraines, helping to reduce the frequency of migraine episodes.

Qulipta is taken orally, typically once daily, as directed by a healthcare provider.

Common side effects may include nausea, constipation, fatigue, upper respiratory tract infection, and muscle pain.

It's important to consult with a healthcare provider before taking Qulipta with other medications to avoid potential interactions.

Qulipta should be stored as directed, typically at room temperature, and kept out of reach of children and pets.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.